Master regulators of FGFR2 signalling and breast cancer risk

Nature Communications

Volumn 4, Issue , 2013, Pages

  Fletcher, Michael N C ^a,b   Castro, Mauro A A ^a,c   Wang, Xin ^a   De Santiago, Ines ^a   O'Reilly, Martin ^a   Chin, Suet Feung ^a   Rueda, Oscar M ^a   Caldas, Carlos ^a   Ponder, Bruce A J ^a   Markowetz, Florian ^a   Meyer, Kerstin B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FRIEDRICH MIESCHER LABORATORY OF THE MAX PLANCK SOCIETY   (Germany)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR 2; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; SECURIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA 3;

CANCER; GENE EXPRESSION; GENOME; HEALTH RISK; MOLECULAR ANALYSIS; WOMENS HEALTH;

ARTICLE; BREAST CANCER; CANCER RISK; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; QUANTITATIVE TRAIT LOCUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC LINKAGE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MCF-7 CELLS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REGULON; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84891925011     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3464     Document Type: Article

References (57)

1. Michailidou, K. et al. Large-scale genotyping identifies 41 novel breast cancer susceptibility loci. Nat. Genet. 45, 392-398 (2013).
2. Easton, D. F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007).
3. Hunter, D. J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870-874 (2007).
4. Udler, M. S. et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum. Mol. Genet. 18, 1692-1703 (2009).
5. Garcia-Closas, M. et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS. Genet. 4, e1000054 (2008).
6. Meyer, K. B. et al. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol. 6, e108 (2008).
7. Riaz, M. et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. Breast Cancer Res. Treat. 133, 843-851 (2012).
8. Li, Q. et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633-641 (2013).
9. Lu, P., Ewald, A. J., Martin, G. R. & Werb, Z. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev. Biol. 321, 77-87 (2008).
10. Kim, S. et al. FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells. PLoS One 8, e51671 (2013).
11. Turner, N. & Grose, R. Fibroblast growth factor receptor signalling: from development to cancer. Nat. Rev. Cancer 10, 118-129 (2010).
12. Muller, F. J. et al. Regulatory networks define phenotypic classes of human stem cell lines. Nature 455, 401-405 (2008).
13. Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318-325 (2010).
14. Basso, K. et al. Reverse engineering of regulatory networks in human B cells. Nat. Genet. 37, 382-390 (2005).
15. Margolin, A. A. et al. Reverse engineering cellular networks. Nat. Protoc. 1, 662-671 (2006).
16. Zhang, X. et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694-15700 (2006).
17. Xian, W., Schwertfeger, K. L. & Rosen, J. M. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol. Endocrinol. 21, 987-1000 (2007).
18. Cowper-Sal lari, R. et al. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 44, 1191-1198 (2012).
19. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346-352 (2012).
20. TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
21. Allred, D. C., Brown, P. & Medina, D. The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res. 6, 240-245 (2004).
22. Kouros-Mehr, H., Kim, J. W., Bechis, S. K. & Werb, Z. GATA-3 and the regulation of the mammary luminal cell fate. Curr. Opin. Cell. Biol. 20, 164-170 (2008).
23. Bernardo, G. M. et al. FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis. Development 137, 2045-2054 (2010).
24. Van Vlierberghe, P. et al. ETV6 mutations in early immature human T cell leukemias. J. Exp. Med. 208, 2571-2579 (2011).
25. Venet, D., Dumont, J. E. & Detours, V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS. Comput. Biol. 7, e1002240 (2011).
26. Carroll, J. S. et al. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38, 1289-1297 (2006).
27. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 43, 27-33 (2010).
28. Theodorou, V., Stark, R., Menon, S. & Carroll, J. GATA3 acts upstream of FOXA1 in mediating ER binding by shaping enhancer accessibility. Genome Res. 23, 12-22 (2013).
29. Wei, G. H. et al. Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. EMBO J. 29, 2147-2160 (2010).
30. Castro, M. A. A., Wang, X., Fletcher, M. N. C., Meyer, K. B. & Markowetz, F. RedeR: R/Bioconductor package for representing modular structures, nested networks and multiple levels of hierarchical associations. Genome Biol. 13, R29 (2012).
31. Wu, L. et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414, 457-462 (2001).
32. Laoukili, J. et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol. 7, 126-136 (2005).
33. Lefebvre, C. et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol. Syst. Biol. 6, 377 (2010).
34. Schadt, E. E. Molecular networks as sensors and drivers of common human diseases. Nature 461, 218-223 (2009).
35. Bernal, J. A. et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat. Genet. 32, 306-311 (2002).
36. Ding, L. et al. Ligand-independent activation of estrogen receptor alpha by XBP-1. Nucleic Acids Res. 31, 5266-5274 (2003).
37. Kong, S. L., Li, G., Loh, S. L., Sung, W. K. & Liu, E. T. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state. Mol. Syst. Biol. 7, 526 (2011).
38. French, J. et al. Fine scale mapping and functional analysis of the breast cancer 11q13 (CCND1) locus. Am. J. Hum. Genet. 92, 1-15 (2013).
39. Steffan, J. J. & Koul, H. K. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor. Cancer Lett. 310, 109-117 (2011).
40. Turcotte, S., Forget, M. A., Beauseigle, D., Nassif, E. & Lapointe, R. Prostate-derived Ets transcription factor overexpression is associated with nodal metastasis and hormone receptor positivity in invasive breast cancer. Neoplasia 9, 788-796 (2007).
41. Sood, A. K. et al. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. Hum. Pathol. 38, 1628-1638 (2007).
42. Feldman, R. J., Sementchenko, V. I., Gayed, M., Fraig, M. M. & Watson, D. K. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 63, 4626-4631 (2003).
43. Oettgen, P. et al. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem. 275, 1216-1225 (2000).
44. Steffan, J., Koul, S., Meacham, R. & Koul, H. The transcription factor SPDEF suppresses prostate tumour metastasis. J. Biol. Chem. 287, 29968-29978 (2012).
45. Wang, K., Li, M. & Hakonarson, H. Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet. 11, 843-854 (2010).
46. Schadt, E. E., Friend, S. H. & Shaywitz, D. A. A network view of disease and compound screening. Nat. Rev. Drug. Discov. 8, 286-295 (2009).
47. Dunning, M. J., Smith, M. L., Ritchie, M. E. & Tavare, S. Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23, 2183-2184 (2007).
48. Schmidt, D. et al. ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240-248 (2009).
49. Park, Y. Y. et al. Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer. EMBO Mol. Med. 4, 52-67 (2012).
50. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).
51. R-Core-Team. R: A Language and Environment For Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, ISBN 3-900051-07-0, 2012).
52. Meyer, P. E., Lafitte, F. & Bontempi, G. Minet: A R/Bioconductor package for inferring large transcriptional networks using mutual information. BMC Bioinformat. 9, 461 (2008).
53. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-15550 (2005).
54. Weinstock, G. M. ENCODE: more genomic empowerment. Genome Res. 17, 667-668 (2007).
55. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
56. Karolchik, D. et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32, D493-D496 (2004).
57. Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 37, W202-W208 (2009).